A phase 3, open-label, randomized study to evaluate the efficacy and safety of single-agent belantamab mafodotin (belamaf) compared to pomalidomide plus low-dose dexamethasone (Pd) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): DREAMM-3
Weisel, Katja, Hungria, Vania TM, Radinoff, Atanas, Delimpasi, Sosana, Mikala, Gabor, Masszi, Tamas, Li, Jian, Capra, Marcelo, Matsumoto, Morio, Sule, Neal, Li, Mary, McKeown, Astrid, He, Wei, Bright, Shelley, Currie, Brooke, Boyle, Julia, Opalinska, Joanna, Dimopoulos, Meletios A.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Multiple myeloma with t(11;14): unique biology and evolving landscape
Bal, Susan, Kumar, Shaji K, Fonseca, Rafael, Gay, Francesca, Hungria, Vania Tm, Dogan, Ahmet, Costa, Luciano J
Published in American journal of cancer research (01.01.2022)
Get full text
Published in American journal of cancer research (01.01.2022)
Journal Article
Efficacy and safety of daratumumab, bortezomib, and dexamethasone (D-Vd) in relapsed or refractory multiple myeloma (RRMM) based on cytogenetic risk: Updated subgroup analysis of CASTOR
Weisel, Katja, Spencer, Andrew, Lentzsch, Suzanne, Avet-Loiseau, Herve, Mark, Tomer M., Spicka, Ivan, Bosi, Alberto, Hungria, Vania TM, Cavo, Michele, Lee, Je-Jung, Nooka, Ajay K., Quach, Hang, Munder, Markus, Beksac, Meral, Sonneveld, Pieter, Soong, David, Ukropec, Jon, Qi, Ming, Mateos, Maria-Victoria
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma
Hájek, Roman, Minařík, Jiří, Straub, Jan, Pour, Luděk, Jungova, Alexandra, Berdeja, Jesus G, Boccadoro, Mario, Brozova, Lucie, Spencer, Andrew, Rhee, Frits van, Vela-Ojeda, Jorge, Thompson, Michael A, Abonour, Rafat, Chari, Ajai, Cook, Gordon, Costello, Caitlin L, Davies, Faith E, Hungria, Vania Tm, Lee, Hans C, Leleu, Xavier, Puig, Noemi, Rifkin, Robert M, Terpos, Evangelos, Usmani, Saad Z, Weisel, Katja C, Zonder, Jeffrey A, Bařinová, Magda, Kuhn, Matyáš, Šilar, Jiří, Čápková, Lenka, Galvez, Kenny, Lu, Jin, Elliott, Jennifer, Stull, Dawn Marie, Ren, Kaili, Maisnar, Vladimír
Published in Future oncology (London, England) (01.07.2021)
Published in Future oncology (London, England) (01.07.2021)
Get full text
Journal Article
Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma
Richardson, Paul G, Laubach, Jacob P, Lonial, Sagar, Moreau, Philippe, Yoon, Sung-Soo, Hungria, Vânia T M, Dimopoulos, Meletios A, Beksac, Meral, Alsina, Melissa, San-Miguel, Jesús F
Published in Expert review of anticancer therapy (01.07.2015)
Published in Expert review of anticancer therapy (01.07.2015)
Get more information
Journal Article
Efficacy and safety of the randomized, open-label, non-inferiority, phase 3 study of subcutaneous (SC) versus intravenous (IV) daratumumab (DARA) administration in patients (pts) with relapsed or refractory multiple myeloma (RRMM): COLUMBA
Mateos, Maria-Victoria, Nahi, Hareth, Legiec, Wojciech, Grosicki, Sebastian, Vorobyev, Vladimir, Spicka, Ivan, Hungria, Vania TM, Korenkova, Sibirina, Bahlis, Nizar J., Flogegard, Max, Blade, Joan, Moreau, Philippe, Kaiser, Martin, Iida, Shinsuke, Laubach, Jacob, Ahmadi, Tahamtan, Parasrampuria, Dolly A., Peng, Lixian, Qi, Ming, Usmani, Saad Zafar
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2019)
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2019)
Get full text
Journal Article
Conference Proceeding
Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
Maiolino, Angelo, Hungria, Vania T.M., Garnica, Marcia, Oliveira-Duarte, Gislaine, Oliveira, Luciana C.O., Mercante, Daniel R., Miranda, Eliana C., Quero, Adriana A., Peres, Ana L.M., Barros, José C., Tanaka, Paola, Magalhães, Roberto P., Rego, Eduardo M., Lorand-Metze, Irene, Lima, Carmen S.P., Renault, Ilana Z., Braggio, Esteban, Chiattone, Carlos, Nucci, Marcio, de Souza, Carmino A.
Published in American journal of hematology (01.10.2012)
Published in American journal of hematology (01.10.2012)
Get full text
Journal Article
Efficacy and Safety Based on Duration of Treatment of Panobinostat Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma in the Phase 3 Panorama 1 Study
San Miguel, Jesus, Hungria, Vania TM, Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios A., Elghandour, Ashraf, Jedrzejczak, Wieslaw Wiktor, Guenther, Andreas, Na Nakorn, Thanyaphong, Siritanaratkul, Noppadol, Schlossman, Robert L, Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae-Hoon, Einsele, Hermann, Salwender, Hans, Sopala, Monika, Redhu, Suman, Paul, Sofia, Corrado, Claudia, Binlich, Florence, Richardson, Paul G.
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia
de Lima, Luciene Terezina, Vivona, Douglas, Bueno, Carolina Tosin, Hirata, Rosario D. C., Hirata, Mario H., Luchessi, André D., de Castro, Fabíola Attié, Chauffaille, Maria de Lourdes F., Zanichelli, Maria A., Chiattone, Carlos S., Hungria, Vania T. M., Guerra-Shinohara, Elvira M.
Published in Medical oncology (Northwood, London, England) (01.03.2014)
Published in Medical oncology (Northwood, London, England) (01.03.2014)
Get full text
Journal Article
Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin's and non-Hodgkin's lymphoma and a preliminary study on the toxicity of etoposide associated with LDE
PINHEIRO, Ketlin V, HUNGRIA, Vania T. M, FICKER, Elisabeth S, VALDUGA, Claudete J, MESQUITA, Carlos H, MARANHAO, Raul C
Published in Cancer chemotherapy and pharmacology (01.05.2006)
Published in Cancer chemotherapy and pharmacology (01.05.2006)
Get full text
Journal Article
Analysis of Outcomes Based on Response in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma Treated with Panobinostat or Placebo in Combination with Bortezomib and Dexamethasone in the Panorama 1 Trial: Updated Analysis Based on Prior Treatment
San Miguel, Jesús F, Hungria, Vânia TM, Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios A., Elghandour, Ashraf, Jedrzejczak, Wieslaw W., Guenther, Andreas, Nakorn, Thanyaphong Na, Siritanaratkul, Noppadol, Schlossman, Robert L., Hou, Jian, Moreau, Philippe, Lonial, Sagar, Lee, Jae Hoon, Einsele, Hermann, Sopala, Monika, Bengoudifa, Bourras-Rezki, Corrado, Claudia, Binlich, Florence, Richardson, Paul G.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article